Literature DB >> 2456370

An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes.

D W Mann1, E McLaughlin-Taylor, R B Wallace, J Forman.   

Abstract

CTL derived from (C3H x B6.K1)F1 animals were sensitized against L cells that express the transfected gene product Q10d/Ld. These CTL were highly crossreactive against three other class I molecules, H-2Kbm1, H-2Ld, and H-2Kd. In an attempt to define this crossreactive epitope it was noted that between 25 and 39% of amino acids in the alpha helices and central beta strands of these three molecules vary from Q10d. These amino acids represent residues that have been proposed to potentially interact with a peptide antigen or TCR (21). However, all four molecules share the amino acid tyrosine at positions 155 and 156. Additionally, Q10d, H-2Kbm1, and H-2Ld share alanine at position 152, while H-2Kd has an aspartic acid. We showed that these residues were important in controlling this epitope by the finding that anti-Q10d CTL did not recognize H-2Kbm1 revertant molecules that had either the position 152 alanine changed back to the wild-type H-2Kb residue (glutamic acid) or position 155 and 156 tyrosines changed back to wild-type residues arginine and leucine. Further evidence that these molecules share a crossreactive epitope was noted by the failure of (C3H x H-2Kbm1)F1 animals to generate CTL that recognized H-2Ld or H-2Kd, and the inability of (C3H x BALB/c)F1 animals to generate CTL reactive against H-2Kbm1. CTL from these mice were still able to recognize Q10d/Ld indicating that other epitopes could be detected if natural tolerance prevented recognition of the crossreactive epitope. To further define the epitope, CTL clones were generated against Q10d/Ld and maintained on either H-2Kbm1 or BALB/c feeder cells. In addition to testing these clones on the target cells described above, mutant molecules derived from H-2Ld, which have amino acid substitutions in their alpha 1 domain, were analyzed. It was noted that some anti-Q10 clones that did not crossreact on H-2Ld did react against H-2Ld mutant antigens that had H-2Dd amino acid substitutions in the alpha 1 domain at positions 63, 65, 66, and 70. Other clones had differential reactivities on these H-2Ld mutants further substantiating that alpha 1 domain amino acids play a role in controlling the expression of the crossreactive epitope. Thus, four class I molecules with multiple amino acid differences in their alpha 1 and alpha 2 domains share a crossreactive epitope readily recognized by alloreactive CTL.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456370      PMCID: PMC2188981          DOI: 10.1084/jem.168.1.307

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  51 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants.

Authors:  L P de Waal; W M Kast; R W Melvold; C J Melief
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

3.  Biochemical studies on the H-2K antigens of the MHC mutant bml.

Authors:  T Nisizawa; B M Ewenstein; H Uehara; D McGovern; S G Nathenson
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  Fine specificity of cytotoxic T lymphocytes directed against H-2Ld.

Authors:  C J Melief; L P de Waal; M Y van der Meulen; P Iványi; R W Melvold
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

Review 5.  Biochemistry of the gene products from murine MHC mutants.

Authors:  R Nairn; K Yamaga; S G Nathenson
Journal:  Annu Rev Genet       Date:  1980       Impact factor: 16.830

6.  On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes.

Authors:  T J Braciale; V L Braciale; M Winkler; I Stroynowski; L Hood; J Sambrook; M J Gething
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

7.  Clonal analysis of cytolytic T lymphocyte specificity. I. Phenotypically distinct sets of clones as the cellular basis of cross-reactivity to alloantigens.

Authors:  C Taswell; H R MacDonald; J C Cerottini
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

8.  Dissection of the B10.D2 anti-H-2Kb cytolytic T lymphocyte receptor repertoire.

Authors:  L A Sherman
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

9.  Fine specificity of alloimmune cytotoxic T lymphocytes directed against H-2K. A study with Kb mutants.

Authors:  C J Melief; L P de Waal; M Y van der Meulen; R W Melvold; H I Kohn
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

10.  An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity.

Authors:  T T Wu; E A Kabat
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

View more
  4 in total

1.  Peripheral tolerance in mice expressing a liver-specific class I molecule: inactivation/deletion of a T-cell subpopulation.

Authors:  K Wieties; R E Hammer; S Jones-Youngblood; J Forman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes.

Authors:  C A Olson; L C Williams; E McLaughlin-Taylor; M McMillan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.

Authors:  J Kan-Mitchell; X Q Huang; L Steinman; J R Oksenberg; W Harel; J W Parker; P S Goedegebuure; T L Darrow; M S Mitchell
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

4.  Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients.

Authors:  J Kan-Mitchell; P E Liggett; W Harel; L Steinman; T Nitta; J R Oksenberg; M R Posner; M S Mitchell
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.